A Final Word on GPOs
Executive SummaryChanges will likely come as a result of the intense public scrutiny that the GPO industry has been under for the past year, a scrutiny encouraged and to a large degree prompted by small medical device companies. The question of precisely in what ways leading GPOs will operate differently is, itself, an important part of the public debate. Yet, it's hard not to conclude that, no matter how GPOs reform themselves, the debate itself has left some fundamental questions on the table.
You may also be interested in...
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.